Rapamycin ameliorates psoriasis by regulating the expression and methylation levels of tropomyosin via ERK1/2 and mTOR pathways in vitro and in vivo | |
Gao, Minhong; Si, Xiaoqing | |
刊名 | EXPERIMENTAL DERMATOLOGY
![]() |
2018 | |
卷号 | 27期号:10页码:1112-1119 |
关键词 | DNA methylation Psoriasis rapamycin TNF- tropomyosin |
DOI | 10.1111/exd.13745 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4569354 |
专题 | 山东大学 |
作者单位 | Shangdong Univ, Dept Dermatol, Qianfoshan Hosp, 16766 Jingshi Rd, Jinan 250014, Shandong, Peoples R China. |
推荐引用方式 GB/T 7714 | Gao, Minhong,Si, Xiaoqing. Rapamycin ameliorates psoriasis by regulating the expression and methylation levels of tropomyosin via ERK1/2 and mTOR pathways in vitro and in vivo[J]. EXPERIMENTAL DERMATOLOGY,2018,27(10):1112-1119. |
APA | Gao, Minhong,&Si, Xiaoqing.(2018).Rapamycin ameliorates psoriasis by regulating the expression and methylation levels of tropomyosin via ERK1/2 and mTOR pathways in vitro and in vivo.EXPERIMENTAL DERMATOLOGY,27(10),1112-1119. |
MLA | Gao, Minhong,et al."Rapamycin ameliorates psoriasis by regulating the expression and methylation levels of tropomyosin via ERK1/2 and mTOR pathways in vitro and in vivo".EXPERIMENTAL DERMATOLOGY 27.10(2018):1112-1119. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论